| Literature DB >> 29018298 |
Abstract
In an effort to control costs, the Centers for Medicare and Medicaid Services wants to exact a severe reduction in reimbursement to hospitals that participate in the 340B Drug Pricing Program. The author discusses the program's shortcomings, the actions taken to address them, and how participating hospitals might be affected by the cut.Year: 2017 PMID: 29018298 PMCID: PMC5614413
Source DB: PubMed Journal: P T ISSN: 1052-1372